Mon. May 25th, 2026
Spread the love

The total contribution to the Private Sector Coalition Against COVID-19 (CACOVID) set up by the Central Bank of Nigeria (CBN) to raise funds to combat the pandemic is now N19.488 billion as at yesterday, up from the N15.325 billion reported on Wednesday. This amount, however, excludes the N3.4 billion pledges by four individuals and organisations yet to be redeemed.
 
The Director, Corporate Communications, CBN, Isaac Okorafor, disclosed this in a statement on behalf of CACOVID-19. The list of contributors to the fund has increased to 47 individuals and organisations (excluding the four yet to redeem their pledges), higher than the 37 recorded on Wednesday. The updated list showed Takagro Chemicals Limited, Atiku Abubakar, Ekeoma Ekeoma, Ahmadu Mahmoud, Jennifer Ramatu Etuh Foundation, ADG International Resources, and Prosharena Limited, were the latest contributors.

The objective of CACOVID is to mobilize private sector thought leadership and private sector resources; increase general public awareness, education, and buy-in; and provide direct support to private and public healthcare ability to respond to the crisis as well as support the federal government’s efforts.
Okorafor noted that the coalition thanked the donors for hearkening to the clarion call championed by the CBN and the private sector. He, however, urged more Nigerians and corporate bodies to key into the coalition with a view to supporting the fight against the pandemic, stressing that Nigeria could overcome the scourge with support from all.

CACOVID had on Monday, disclosed that work had started in earnest to provide and equip medical facilities in the six geopolitical zones. The medical facilities included the creation of testing, isolation and treatment centres, as well as the provision of Intensive Care Units (ICUs) and molecular testing labs. A breakdown of this had shown that 1,000 beds were donated to Lagos; Kano (500); Rivers (210) Abuja (200); Enugu (200); and Borno (200); and expect to be operational within 10 days. “The next phase will see locations set up in Katsina, Ogun, Bayelsa, Anambra, Bauchi and Plateau to be ready within three weeks. The remaining states of the Federation will be set up in the last phase within the next five weeks,” the group had started.

CBN Governor, Godwin Emefiele, had said CACOVID was targeting N120 billion for the acquisition of healthcare facilities and advocacy about the virus across the country, among others. Emefiele had explained that four major committees have been set up which include the Steering Committee; the Funding Committee; Operational Committee and the Technical Committee.

“This coalition was created out of the urgent need to combat the unfolding COVID-19 crisis in Nigeria. The rate at which the virus is spreading is unprecedented and it appears we are fighting our most lethal adversary today. So far, the federal government has made strides in the fight, but, it is clear that the private sector needs to step in to support efforts being made,” the CBN governor had said.

A breakdown of the earlier contributions to the fund showed that the CBN and President, Dangote Group, Alhaji Aliko Dangote donated N2 billion each into the fund while Alhaji Abdul Samad Rabiu (Bua Sugar Refinery); Segun Agbaje (GTBank); Tony Elumelu (United Bank for Africa); Chief Oba Otudeko (First Bank); Chief Jim Ovia (Zenith Bank); Herbert Wigwe (Access Bank); and Femi Otedola of Amperion Power Distribution, donated N1 billion each.

Other donors included Pacific Holding Ltd, Union Bank Plc, Sterling Bank Plc, Standard Chartered Bank, Stanbic IBTC, Citi Bank Nigeria Ltd, FCMB, Fidelity Bank, Ecobank Nigeria, African Steel Mills and Multichoice Nigeria Limited. Other contributors include FSDH Merchant Bank, FBN Merchant Bank, Rand Merchant Bank, Coronation Merchant Bank, Sun Trust Bank, Providus Bank, Wema Bank, Unity Bank, Heritage Bank, Nova Merchant Bank, Polaris Bank, and Keystone Bank. Also, Globus Bank, Titan Trust Bank, Takagro Chemicals Ltd, Ahmadu Mahmoud, and Handy Capital Ltd made up the list of those that have so far made contributions into the CACOVID relief fund domiciled at the CBN.

By admin

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.